124 related articles for article (PubMed ID: 4354104)
1. Evaluation of the effectiveness of treatment on adult height prognosis in disorders with advanced and retarded bone age. Height and height velocity related to chronological or to bone age.
Bossi E; Joss EE; Zurbrügg RP
Acta Paediatr Scand; 1973 Jul; 62(4):401-4. PubMed ID: 4354104
[No Abstract] [Full Text] [Related]
2. Improvement of adult height prognosis in precocious puberty by cyproterone acetate.
Bossi E; Zurbrügg RP; Joss EE
Acta Paediatr Scand; 1973 Jul; 62(4):405-12. PubMed ID: 4354105
[No Abstract] [Full Text] [Related]
3. Cyproterone acetate in the treatment of infantile adrenogenital syndrome with precocious puberty.
Beyer J; Demisch K; Wiegelmann W; Happ J; Kollmann F; Schöffling K
Acta Endocrinol Suppl (Copenh); 1973; 173():169. PubMed ID: 4542094
[No Abstract] [Full Text] [Related]
4. The effect of cyproterone acetate on the growth of children with central precocious puberty.
Stanhope R; Huen KF; Buzi F; Preece MA; Grant DB
Eur J Pediatr; 1987 Sep; 146(5):500-3. PubMed ID: 2960531
[TBL] [Abstract][Full Text] [Related]
5. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
Cara JF; Kreiter ML; Rosenfield RL
J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
[TBL] [Abstract][Full Text] [Related]
6. Use of cyproterone acetate in animal and clinical trials.
Neumann F
Gynecol Invest; 1971; 2(1):150-79. PubMed ID: 4949823
[No Abstract] [Full Text] [Related]
7. Treatment of precocious puberty with cyproterone acetate.
Werder EA; Mürset G; Zachmann M; Brook CG; Prader A
Pediatr Res; 1974 Apr; 8(4):248-56. PubMed ID: 4362731
[No Abstract] [Full Text] [Related]
8. Precocious puberty. Three cases and a review of current treatment.
O'Hara MJ; Devlin JG
Ir Med J; 1981 Nov; 74(11):325-7. PubMed ID: 7031012
[No Abstract] [Full Text] [Related]
9. Treatment with a gonadotropin-releasing-hormone analog and attainment of full height potential in a male monozygotic twin with gonadotropin-releasing hormone-dependent precocious puberty.
Ishii T; Sato S; Anzo M; Sasaki G; Hasegawa T; Tamai S; Matsuo N
Eur J Pediatr; 1999 Nov; 158(11):933-5. PubMed ID: 10541952
[TBL] [Abstract][Full Text] [Related]
10. The treatment of precocious puberty with cyproterone acetate.
Rager K; Huenges R; Gupta D; Bierich JR
Acta Endocrinol (Copenh); 1973 Oct; 74(2):399-408. PubMed ID: 4270254
[No Abstract] [Full Text] [Related]
11. Body proportions in precocious puberty.
Martinez L; Preece MA; Grant DB
Acta Paediatr Scand; 1984 Mar; 73(2):185-8. PubMed ID: 6234747
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC
Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
[TBL] [Abstract][Full Text] [Related]
13. Treatment of idiopathic precocious puberty with cyproterone acetate. Proceedings of a discussion, Berlin, April 29, 1977.
Horm Res; 1978; 9(5):301-12. PubMed ID: 210100
[No Abstract] [Full Text] [Related]
14. Effects of puberty on bone age maturation in a girl after medulloblastoma therapy.
Marx M; Schoof E; Grabenbauer GG; Beck JD; Doerr HG
J Pediatr Adolesc Gynecol; 1999 May; 12(2):62-6. PubMed ID: 10326189
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin releasing hormone analogue and growth hormone therapy in precocious and premature puberty following cranial irradiation for acute lymphoblastic leukaemia.
Thomas BC; Stanhope R; Leiper AD
Horm Res; 1993; 39(1-2):25-9. PubMed ID: 8406336
[TBL] [Abstract][Full Text] [Related]
16. Growth and precocious puberty.
Chaussain JL; Couprie C; Lacaille F; Simon D; Job JC
Acta Paediatr Scand Suppl; 1988; 347():38-43. PubMed ID: 2978196
[TBL] [Abstract][Full Text] [Related]
17. Adult height exceeding target height in a patient with congenital panhypopituitarism diagnosed after the age of 25 years.
Arrigo T; Crisafulli G; Salamone A; Cucinotta D; De Luca F
J Pediatr Endocrinol; 1994; 7(3):269-72. PubMed ID: 7820223
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of growth retardation with special reference to the problem of hypopituitarism.
Root AW; Bongiovanni AM; Eberlein WR
J Pediatr; 1971 May; 78(5):737-53. PubMed ID: 5581580
[No Abstract] [Full Text] [Related]
19. Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method.
Kauli R; Galatzer A; Kornreich L; Lazar L; Pertzelan A; Laron Z
Horm Res; 1997; 47(2):54-61. PubMed ID: 9030968
[TBL] [Abstract][Full Text] [Related]
20. [Long-term experiences with a long-acting gonadotropin releasing hormone analog in therapy of central precocious puberty: effect on body growth].
Hofmann-Ehrhart B; Schulz U; Kluge M; Wandl-Vergesslich K; Waldhauser F
Wien Klin Wochenschr; 1995; 107(14):413-7. PubMed ID: 7668000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
